Robert Doebele - Mar 31, 2022 Form 4 Insider Report for Rain Therapeutics Inc. (RAIN)

Role
President, Chief Scientific Officer
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
Stock symbol
RAIN
Transactions as of
Mar 31, 2022
Transactions value $
$7,900
Form type
4
Date filed
4/4/2022, 04:15 PM
Previous filing
Feb 4, 2022
Next filing
Apr 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RAIN Common Stock Options Exercise $7.9K +2K +0.43% $3.95 470K Mar 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Options Exercise $0 -2K -14.4% $0.00 11.9K Mar 31, 2022 Common Stock 2K $3.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.

Remarks:

President, Chief Scientific Officer